Drug Research

ChargePoint Technology, a specialist in powder and liquid transfer, has invested in a new manufacturing facility dedicated to its single-use products in Speke, Liverpool, to address an increased demand in the market for disposable technologies and equipment. The new...

As the EU health ministers go on to gather in Brussels on April 23–24 in order to discuss access when it comes to critical medicines and go on to formally launch the Critical Medicines Alliance, the European Medicines Agency-...

In the ever-changing pharma and biologics sector, the Biologics Clinical Manufacturing CDMO Service market has gone on to emerge as quite a prominent player in the global economy, thereby going ahead and also exhibiting noteworthy growth and at the...

It is worth noting that the Cell and gene therapies- CGTs have gone on to show immense promise when it comes to treating diverse conditions, right from cancer to neurodegenerative diseases. But, alongside their potential perks, they go on...

Asahi Kasei Bioprocess America, Inc (AKB), part of the Asahi Kasei Group, and Axolabs have announced a strategic partnership in the burgeoning field of oligonucleotide therapeutics. The partners will collaborate to build a cutting-edge oligonucleotide cGMP manufacturing facility spanning...

QIAGEN announced that its NeuMoDx human immunodeficiency virus type 1 (HIV-1) assay has received approval for use in Thailand. Along with the previously approved hepatitis B virus (HBV) and hepatitis C virus (HCV) quantitative assays there is now a...

A new study which has been led by Prof. Meital Reches from the Hebrew University, along with Mr. Daniel Boas, one of the Ph.D. students in her group, as well as the team of collaborators, has gone on to...